AVON Pension Fund has achieved a UK first by being appointed lead plaintiff in a US class action lawsuit against GlaxoSmithKline.
The pharmaceutical company is accused of misleading investors over the safety and efficacy of its diabetes drug Avandia. A United State District Court in the southern district of New York appoin...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders